<a href="https://laohu8.com/S/ELAT">Elanco Animal Health</a> Secures $1.1 Billion Loan in Credit Agreement Amendment
Elanco Animal Health Inc. has entered into Amendment No. 3 to its existing Credit Agreement, originally dated August 1, 2020. The amendment, completed on October 31, 2025, involves a consortium of lenders and financial institutions including JPMorgan Chase Bank, N.A., Wilmington Trust, and others. Under the revised terms, Elanco secured new U.S. dollar-denominated term loans totaling $1.1 billion with a maturity date of October 31, 2032, a new tranche of €400 million euro-denominated senior secured term loans maturing April 30, 2029, and $540 million in farm credit term loans also maturing October 31, 2032. The proceeds, combined with company cash, were used to refinance all outstanding borrowings under Elanco's previous term loan B facility due 2027 and to pay related fees and expenses. The amendment also introduced various changes to the covenants and terms of the original Credit Agreement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-105246), on November 03, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.